Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter randomized trial of 5% diquafosol ophthalmic solution in short BUT dry eye disease
KCT0011521Phase 4Not yet recruiting
- Sponsor
- Taejoon Pharmaceutical Co., Ltd.
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of diquafosol in dry eye syndrome (DED) (2 arms), sponsored by Taejoon Pharmaceutical Co., Ltd. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
diquafosol
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on KCT0011521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0011521.